Particles between 1 and 100 nanometers (nm) in
size known as nanoparticles. An individual nanoparticle molecule
behaves as a complete unit in terms of its property and
transportation. Rapidly increasing public awareness for
nanotechnology and introduction of new technologies will have many
beneficial consequences. Moreover, increasing applications of
nanotechnology in drug development and stringent guidelines for
developing improved medical products are some of the prime factors
which is expected to witness significant growth over the forecasted
period. Furthermore, huge capital investment and high cost of
nanoparticle analysis instrument is one of the key restraint for the
growth of nanoparticle market. Due to its wide applications in
healthcare, biomedical, electronics and among others the nanoparticle
is currently a new area of research among many scientist. Rising
government spending on pharmaceuticals and bio technology research
and development and increasing focus on nanotechnology research also
expected to experience significant growth. North America dominated
the global nanoparticles market due to increasing chronic diseases
such as diabetes, cardiovascular and cancer. Moreover, Europe is
expected to witness the highest growth during the forecasted period,
due to rapid research and development for nanoparticles. However, due
to rampant economic growth of China and India, Asia Pacific is also
expected to witness decent growth during the forecasted period.
Furthermore, India is also an emerging hub for pharmaceuticals
research and development.
Fill the form for an exclusive sample of
Nanoparticles Market report @
https://www.coherentmarketinsights.com/insight/request-sample/216
Nanoparticles Market Taxonomy
On the basis of technology, the global market is
classified into:
-
Liposomes
-
Nanotubes
-
Polymeric nanoparticles
-
Polymer conjugated drugs
-
Dendrimers
-
Inorganic nanoparticles
-
Others
On the basis of end user, the global market is
classified into:
-
Pharmaceuticals industry
-
Biochemical industry
-
Research institutions
-
others
Nanoparticles Market Outlook – Surge in
Drug Development in Pharmaceuticals Industry Augmenting Market Growth
Expansion of medical diagnostic industry and wide
application of nanotechnology in healthcare sector such as neurology,
cardiology and anti-infective is estimated to have a decent growth
for nanoparticles market in the forecast period. Depending upon
preparation methods nanoparticles, nanocapsules or nanospheres can be
obtained. A long circulating particle made up of Biodegradable
polymeric nanoparticles with hydrophilic polymer coating of poly
ethylene glycol (PEG), used as a powerful drug delivery device. Due
to its ability to deliver peptides, proteins and genes, it is also
used as a DNA carrier in gene therapy. Numerous advantages for
nanoparticles in drug delivery system is expected to Spector enormous
growth during the forecasted period. Moreover, growing public
awareness, improved technology and increase in chronic diseases
escalate the global nanoparticles industry in North America. Emerging
economy of Asia Pacific, such as China and India is expected to
witness significant growth over the forecasted period.
Nanoparticles Market Challenges – Huge
Capital Investment needed in Research and Development
Huge capital investment for research and
development of new product and technology. Moreover, high cost of
nanoparticles analysis instruments is expected to be one of the key
restraints for global nanoparticles market.
Nanoparticles Market – Regulatory
Scenario:
-
August, 2015, U.S. Food and Drug Administration (FDA), issued guidance to address various issues related to the use of nanotechnology in food ingredients intended for use in food for animals.
-
June, 2014, U.S. Food and Drug Administration (FDA), issued three guidelines related to the use of nanotechnology in regulated products, including cosmetics and food substances.
Request to view table of content @
https://www.coherentmarketinsights.com/ongoing-insight/toc/216
Some of the key players in the market includes
Abraxis Biosciences, Inc., Novartis International AG, Gilead
Sciences, Inc., Johnson & Johnson, Sigma-Tau Pharmaceuticals,
Inc. Amgen, Inc., and Nano Interface Technology, Inc., Malvern
Instruments Ltd., Horiba Ltd., Beckman Coulter, Shimadzu Corporation,
Agilent Technology Inc, Hitachi Ltd., Wyatt Technology, among others.
About Coherent Market Insights:
Coherent Market Insights is a
prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations
related to emerging market trends, technologies, and potential
absolute dollar opportunity
No comments:
Post a Comment